|
시장보고서
상품코드
2058224
임상시험수탁기관(CRO) 서비스 시장 : 종류별, 치료 분야별, 최종사용자별, 지역별Contract Research Organization Services Market, By Type, By Therapeutic Application, By End User, By Geography |
||||||
임상시험수탁기관(CRO) 서비스 시장은 2026년에 828억 6,000만 달러로 추정되며, 2033년까지 1,375억 2,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 7.5%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 828억 6,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 7.50% | 2033년 시장 규모 예측: | 1,375억 2,000만 달러 |
의약품 및 생명공학 연구개발(R&D)의 아웃소싱 증가, 전 세계 임상시험의 복잡화 및 규모 확대, 그리고 비용 효율적인 의약품 개발 프로세스에 대한 필요성 증대를 배경으로 시장은 강력한 성장세를 보이고 있습니다.
임상시험수탁기관(CRO)는 임상 연구, 초기 단계 개발, 실험실 서비스, 규제 컨설팅 등 폭넓은 서비스를 제공하고 있습니다. 이러한 기관들은 신약 개발 일정을 앞당기는 한편, 후원사가 비용과 규제 요건을 관리할 수 있도록 지원하는 데 있어 매우 중요한 역할을 수행하고 있습니다.
인공지능(AI), 리얼 월드 에비던스(RWE), 분산형 임상시험(DCT) 등의 기술적 진보가 CRO 업계의 양상을 일변시키고 있습니다. 이러한 혁신은 피험자 모집을 강화하고, 데이터 수집을 효율화하며, 시험 기간을 최대 20-30% 단축함으로써 시험의 효율성을 높여줍니다. 또한, 종양학, 희귀질환, 바이오의약품과 같은 복잡한 치료 분야에 대한 관심이 높아지고 있는 점도 전문적인 CRO 기능에 대한 수요를 더욱 부추기고 있습니다. 전 세계적으로 제약 파이프라인이 확대되는 가운데, CRO는 엔드투엔드 의약품 개발의 전략적 파트너로서 지속적으로 진화하고 있습니다.
시장 역학
임상시험수탁기관(CRO) 서비스 시장은 현대 의약품 개발 및 임상 연구 생태계에서 핵심적인 역할을 수행함에 따라 눈부신 성장을 이루고 있습니다. 주요 성장 요인 중 하나는 임상시험 아웃소싱의 증가이며, 현재 임상 연구 활동의 약 65-75%가 CRO와의 제휴를 통해 수행되고 있습니다. 이러한 추세는 의약품 1개당 평균 26억 달러를 넘는 의약품 개발 비용의 급등에 힘입어 나타나고 있으며, 제약 기업들은 비용 대비 효과가 높고 효율적인 해결책을 모색하고 있습니다.
만성 질환, 특히 암으로 인한 부담 증가 역시 시장 수요를 더욱 가속화하고 있습니다. 종양학은 여전히 주요 치료 분야로, 면역요법, 표적요법 및 맞춤형 의료 접근법에 기반한 강력한 파이프라인에 힘입어 시장 점유율의 약 30%를 차지하고 있습니다. 등록된 연구 건수가 47만 건을 넘어서는 등, 전 세계 임상시험의 증가세 또한 CRO 서비스의 범위가 확대되고 있음을 보여줍니다.
규제 측면의 진전, 특히 선진국 시장에서의 진전 또한 시장 성장에 기여하고 있습니다. 승인 절차의 효율화, 실세계 데이터(REW)의 수용 확대, 임상시험용 의약품 심사 기간 단축은 임상시험 활동을 활성화하고, 결과적으로 CRO 서비스에 대한 수요를 높이고 있습니다.
전 세계 제약 및 생명공학 분야의 확대 또한 시장 성장을 더욱 촉진하고 있습니다. 신흥 지역, 특히 아시아태평양은 운영 비용의 저렴함, 의료 인프라의 개선, 그리고 대규모 환자 집단에 대한 접근성을 이유로 주요 아웃소싱 거점으로 부상하고 있습니다. 이러한 요인들 덕분에 환자를 신속하게 모집하고 확장 가능한 임상시험 운영이 가능해집니다.
전반적으로 CRO 서비스 시장은 효율적이고 확장성이 뛰어나며, 혁신 중심의 의약품 개발 프로세스를 가능하게 하는 세계 헬스케어 생태계의 핵심 구성요소로서 지속적으로 발전하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시, 시장 동향, 지역별 전망 및 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표(기업 개요, 서비스 포트폴리오, 주요 발전 사항, 재무 실적, 전략)를 바탕으로 임상시험수탁기관(CRO) 서비스 시장의 주요 업체들을 분석하고 있습니다.
- 본 보고서의 인사이트를 활용함으로써, 마케팅 담당자와 경영진은 향후 서비스 혁신, 시장 확대, 전략적 파트너십과 관련하여 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 임상시험수탁기관(CRO) 서비스 시장 보고서는 투자자, 서비스 제공업체, 제약 기업, 규제 당국, 금융 애널리스트 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 CRO 서비스 시장 평가에 사용되는 체계적인 분석 프레임워크와 전략 매트릭스를 활용함으로써 큰 이점을 얻을 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 임상시험수탁기관(CRO) 서비스 시장 : 유형별, 2021-2033년
제5장 세계의 임상시험수탁기관(CRO) 서비스 시장 : 치료 분야별, 2021-2033년
제6장 세계의 임상시험수탁기관(CRO) 서비스 시장 : 최종사용자별, 2021-2033년
제7장 세계의 임상시험수탁기관(CRO) 서비스 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.06.19Contract Research Organization Services Market is estimated to be valued at USD 82.86 Bn in 2026 and is expected to reach USD 137.52 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 82.86 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.50% | 2033 Value Projection: | USD 137.52 Bn |
The market is experiencing strong expansion driven by the increasing outsourcing of pharmaceutical and biotechnology research and development (R&D), rising complexity and volume of global clinical trials, and the growing need for cost-efficient drug development processes.
CROs provide a broad spectrum of services including clinical research, early-phase development, laboratory services, and regulatory consulting. These organizations play a critical role in accelerating drug discovery and development timelines while helping sponsors manage costs and regulatory requirements.
Technological advancements such as artificial intelligence (AI), real-world evidence (RWE), and decentralized clinical trials (DCTs) are transforming the CRO landscape. These innovations enhance patient recruitment, streamline data collection, and improve trial efficiency by reducing timelines by up to 20-30%. Additionally, the increasing focus on complex therapeutic areas such as oncology, rare diseases, and biologics is further driving demand for specialized CRO capabilities. As pharmaceutical pipelines expand globally, CROs continue to evolve as strategic partners in end-to-end drug development.
Market Dynamics
The Contract Research Organization Services Market is witnessing significant growth due to its central role in modern drug development and clinical research ecosystems. One of the primary growth drivers is the increasing outsourcing of clinical trials, with approximately 65-75% of clinical research activities now conducted through CRO partnerships. This trend is fueled by the rising cost of drug development, which exceeds USD 2.6 billion per drug on average, prompting pharmaceutical companies to seek cost-effective and efficient solutions.
The growing burden of chronic diseases, particularly cancer, is further accelerating market demand. Oncology remains the leading therapeutic segment, accounting for around 30% of the market share, driven by a strong pipeline of immunotherapies, targeted therapies, and personalized medicine approaches. The increasing number of global clinical trials-exceeding 470,000 registered studies, also highlights the expanding scope of CRO services.
Regulatory advancements, particularly in developed markets, are also contributing to market growth. Streamlined approval processes, increased acceptance of real-world evidence, and faster investigational drug review timelines are encouraging more clinical trial activity, thereby boosting demand for CRO services.
The expansion of the global pharmaceutical and biotechnology sectors further supports market growth. Emerging regions, particularly Asia Pacific, are becoming key outsourcing destinations due to lower operational costs, improved healthcare infrastructure, and access to large patient populations. These factors enable faster patient recruitment and scalable clinical trial operations.
Overall, the CRO services market continues to evolve as a vital component of the global healthcare ecosystem, enabling efficient, scalable, and innovation-driven drug development processes.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the Contract Research Organization Services Market based on the following parameters - company highlights, service portfolio, key developments, financial performance, and strategies
- Key companies covered as a part of this study include IQVIA, LabCorp, PAREXEL, ICON plc, PPD, PRA Health Sciences, Syneos Health, Charles River Laboratories, WuXi PharmaTech, Medpace Holdings, SGS, Envigo, and MPI Research
- Insights from this report would allow marketers and management authorities to make informed decisions regarding future service innovations, market expansion, and strategic partnerships
- The Contract Research Organization Services Market report caters to various stakeholders including investors, service providers, pharmaceutical companies, regulatory bodies, and financial analysts
- Stakeholders would benefit from structured analytical frameworks and strategy matrices used in evaluating the CRO services market
Market Segmentation
- By Type (Revenue, USD Bn, 2021-2033)
- Clinical Research Services
- Early Phase Development Services
- Laboratory Services
- Consulting Services
- By Therapeutic Application (Revenue, USD Bn, 2021-2033)
- Oncology
- Infectious Diseases
- Central Nervous System (CNS) Disorders
- Immunological Disorders
- Cardiovascular Diseases
- Respiratory Disorders
- Diabetes
- Other Therapeutic Areas
- By End User (Revenue, USD Bn, 2021-2033)
- Pharmaceuticals & Biopharmaceutical Companies
- Medical Device Companies
- Academic Institutes
- By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- IQVIA
- LabCorp
- PAREXEL
- ICON plc
- PPD
- PRA Health Sciences
- Syneos Health
- Charles River Laboratories
- WuXi PharmaTech
- Medpace Holdings
- SGS
- Envigo
- MPI Research
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Therapeutic Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Global Contract Research Organization Services Market, By Type, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Clinical Research Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Early Phase Development Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Laboratory Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Consulting Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
5. Global Contract Research Organization Services Market, By Therapeutic Application, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Central Nervous System (CNS) Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Immunological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Respiratory Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Other Therapeutic Areas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
6. Global Contract Research Organization Services Market, By End User, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceuticals & Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
7. Global Contract Research Organization Services Market, By Region, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- IQVIA
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- LabCorp
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- PAREXEL
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- ICON plc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- PPD
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- PRA Health Sciences
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Syneos Health
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Charles River Laboratories
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- WuXi PharmaTech
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Medpace Holdings
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- SGS
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Envigo
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- MPI Research
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Analyst Views
- IQVIA
9. Section
- References
- Research Methodology
- About Us
